Lyell Immunopharma shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $114k | 82k | 1.38 |
| 2024-06-30 | $85k | 58k | 1.45 |
| 2024-03-31 | $162k | 73k | 2.23 |
| 2023-12-31 | $136k | 70k | 1.94 |
| 2023-09-30 | $106k | 72k | 1.47 |
| 2023-06-30 | $192k | 60k | 3.18 |
| 2023-03-31 | $250k | 106k | 2.36 |
| 2022-12-31 | $260k | 75k | 3.47 |
| 2022-09-30 | $541k | 74k | 7.33 |
| 2022-06-30 | $533k | 82k | 6.52 |
| 2022-03-31 | $412k | 81k | 5.09 |
| 2021-12-31 | $111k | 14k | 7.74 |
| 2021-09-30 | $201k | 14k | 14.78 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft